BioPharma Resources

Drug Trial Radar · NCT07369154

52-week Open Label Safety-Tolerability Study

A 52 Week, Open Label Safety and Tolerability Study of LB-102 in Adult Patients With Schizophrenia

Last checked: Nov 19, 2026Latest source record: Sep 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

900

Planned (sponsor's estimate)

Start

Apr 23, 2026

Primary completion

Dec 2028

Study completion Apr 2029

Sponsor

Lead sponsor
LB Pharmaceuticals Inc.Industry
Sponsor type
Industry
First posted
Jan 27, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Phase 3, open label, multicenter study designed to assess the long term safety and tolerability of LB-102 for the treatment of adult patients with stable schizophrenia

Conditions

  • Schizophrenia

Interventions

  • LB-102Drug

    LB-102 flexible dosing 50 mg - 100 mg

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evaluate long term safety and tolerability of LB-102 by evaluating the number of adverse event, incidence of treatment emergent events.Time frame: 52 weeks

Locations

23 sites in 1 country. Site status is shown where the registry gives one.

  • Chandler Clinical Trials

    Chandler, Arizona · Recruiting

  • Pillar Clinical Research

    Bentonville, Arkansas · Recruiting

  • Pillar Clinical Research

    Little Rock, Arkansas · Recruiting

  • Woodland International Research Group

    Little Rock, Arkansas · Recruiting

  • Advanced Research Center

    Anaheim, California · Recruiting

  • Synapse Clinical Trials

    Cerritos, California · Recruiting

  • ProScience Research Group

    Culver City, California · Recruiting

  • CenExel

    Culver City, California · Recruiting

  • Synergy San Diego

    San Diego, California · Recruiting

  • CenExel

    Hollywood, Florida · Recruiting

  • Segal Trials

    Miami Lakes, Florida · Recruiting

  • Health Synergy Clinical Research

    West Palm Beach, Florida · Recruiting

  • CenExel

    Atlanta, Georgia · Recruiting

  • Accelerated Clinical Trial

    Snellville, Georgia · Recruiting

  • Pillar Clinical Research

    Chicago, Illinois · Recruiting

  • CenExel Gaithersburg

    Gaithersburg, Maryland · Recruiting

  • Arch Clinical Trials

    St Louis, Missouri · Recruiting

  • Redbird Research

    Las Vegas, Nevada · Recruiting

  • Neuro-Behavioral Clinical Research

    New York, New York · Recruiting

  • Neuro-Behavioral Clinical Research

    Canton, Ohio · Recruiting

  • Adams Clinical

    Philadelphia, Pennsylvania · Recruiting

  • Adams Clinical

    DeSoto, Texas · Recruiting

  • Pillar Clinical Research

    Richardson, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.